{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:12:37Z","timestamp":1793646757292,"version":"4.5.1"},"reference-count":37,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001430"],"award-info":[{"award-number":["UL1TR001430"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Use &amp; Addiction Journal"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Within office-based addiction treatment (OBAT) for opioid use disorder, routine urine drug testing (UDT) has been a near-universal practice, despite concerns about increased stigma and limited evidence on improved patient outcomes. During the COVID-19 pandemic, routine UDT was suspended in many settings as care transformed to telehealth, providing an opportunity to explore viewpoints about routine UDT and the implications of its absence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We explored patient and provider perspectives through qualitative interviews conducted from May 2021 to May 2022 within an urban, low-threshold OBAT program. Semi-structured interview guides and thematic analysis explored opinions on traditional routine UDT and experiences with its discontinuation during the COVID-19 pandemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Based on perspectives of 25 patients and 16 providers, we identified three themes regarding routine UDT and its decreased use during the COVID-19 pandemic: (1) the general utility of UDT within traditional models of care, (2) burdens that routine UDT could present to care engagement, and (3) impacts of UDT on trust within patient\u2013provider relationships.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Our findings support the need for reconsideration of routine UDT in OBAT, as well as the needs for improved care standards. Selective use of UDT can be implemented in a patient-centered manner, including offering it upon patient request (eg, for personal \u201caccountability\u201d) and discontinuing it when appropriate and to reduce barriers to care. In place of routine UDT, our findings also highlight the need for alternative, non-stigmatizing clinical tools that can support patients and providers within OBAT care settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/29767342251360850","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T01:06:42Z","timestamp":1756429602000},"page":"144-152","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Patient and Provider Perspectives on the Elimination of Urine Drug Testing in Office-Based Addiction Treatment"],"prefix":"10.1177","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1105-4377","authenticated-orcid":false,"given":"Jacqueline","family":"Theisen","sequence":"first","affiliation":[{"name":"Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe M.","family":"Weinstein","sequence":"additional","affiliation":[{"name":"Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA"},{"name":"Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center, Boston, MA, USA"},{"name":"Grayken Center for Addiction, Boston Medical Center, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Davoust","sequence":"additional","affiliation":[{"name":"Department of Health Law, Policy, and Management, Boston University School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia S.","family":"Ventura","sequence":"additional","affiliation":[{"name":"Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center, Boston, MA, USA"},{"name":"Grayken Center for Addiction, Boston Medical Center, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara M.","family":"Magane","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences, Boston University School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cheng","sequence":"additional","affiliation":[{"name":"Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Blakemore","sequence":"additional","affiliation":[{"name":"Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center, Boston, MA, USA"},{"name":"Grayken Center for Addiction, Boston Medical Center, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Blodgett","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences, Boston University School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Fielman","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences, Boston University School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Saitz","sequence":"additional","affiliation":[{"name":"Boston University Chobanian &amp; Avedisian School of Medicine, Boston, MA, USA"},{"name":"Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Department of Medicine, Boston Medical Center, Boston, MA, USA"},{"name":"Grayken Center for Addiction, Boston Medical Center, Boston, MA, USA"},{"name":"Department of Community Health Sciences, Boston University School of Public Health, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6828-1919","authenticated-orcid":false,"given":"Angela R.","family":"Bazzi","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences, Boston University School of Public Health, Boston, MA, USA"},{"name":"Herbert Wertheim School of Public Health, University of California, San Diego, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"e_1_3_3_2_2","unstructured":"National Institute on Drug Abuse. Drug overdose deaths: facts and figures. August 21 2024. Accessed April 16 2025. https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.22303"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.7326\/M17-3107"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109445"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1080\/10408444.2018.1553935"},{"issue":"1","key":"e_1_3_3_8_2","first-page":"33","article-title":"Urine drug tests: ordering and interpretation","volume":"99","author":"Kale N.","year":"2019","unstructured":"Kale N. Urine drug tests: ordering and interpretation. Am Fam Physician. 2019;99(1):33-39.","journal-title":"Am Fam Physician"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7217a2"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000323"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2015.0253"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000220"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.08.006"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.4109"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108258"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2020.108155"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000477"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000520185"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.3109\/14659890903431603"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadr.2023.100151"},{"key":"e_1_3_3_21_2","unstructured":"National Academies of Sciences Engineering and Medicine; Action Collaborative on Countering the U.S. Opioid Epidemic; Health and Medicine Division et al. The history of methadone and barriers to access for different populations. In: Methadone Treatment for Opioid Use Disorder: Improving Access Through Regulatory and Legal Change: Proceedings of a Workshop. National Academies Press (US); 2022. Accessed April 25 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK585210\/"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1970.03180020031006"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.0908"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-025-00536-3"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.541"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2015.06.010"},{"key":"e_1_3_3_27_2","unstructured":"Wason KF Potter AL Alves JD et al. Massachusetts nurse care manager model of office based addiction treatment: clinical guidelines. Published online April 2021. Accessed April 16 2025. https:\/\/www.addictiontraining.org\/documents\/resources\/22_2021_Clinical_Guidelines_1.12.2022_fp_th%2528003%2529.29.pdf"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/1525822X10388468"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/1525822X980100020301"},{"key":"e_1_3_3_30_2","unstructured":"Lumivero. NVivo 13 Qualitative Data Analysis Software (NVivo 2020 Release 1). Published online 2020."},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-117"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-01133-4"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.15766\/mep_2374-8265.10684"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108777"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001321"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104206"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/10775587251316919"},{"key":"e_1_3_3_38_2","unstructured":"Centers for Medicare & Medicaid Services. MassHealth: medicaid state waivers. Accessed October 15 2024. https:\/\/www.medicaid.gov\/medicaid\/section-1115-demo\/demonstration-and-waiver-list\/Waiver-Descript-Factsheet\/82006"}],"container-title":["Substance Use &amp; Addiction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29767342251360850","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/29767342251360850","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/29767342251360850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:51:51Z","timestamp":1777600311000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/29767342251360850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1177\/29767342251360850"],"URL":"https:\/\/doi.org\/10.1177\/29767342251360850","relation":{},"ISSN":["2976-7342","2976-7350"],"issn-type":[{"value":"2976-7342","type":"print"},{"value":"2976-7350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]}}}